Gene: GLA
Official Full Name: galactosidase alphaprovided by HGNC
Gene Summary: This gene encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00600 | GLA Knockout cell line(293T) | Human | GLA | 1:3~1:6 | Negative | Online Inquiry |
KO00625 | GLA Knockout cell line (HCT 116) | Human | GLA | 1:2~1:4 | Negative | Online Inquiry |
KO37649 | GLA Knockout cell line (HeLa) | Human | GLA | 1:3~1:6 | Negative | Online Inquiry |
KO37650 | GLA Knockout cell line (HCT 116) | Human | GLA | 1:2~1:4 | Negative | Online Inquiry |
KO37651 | GLA Knockout cell line (A549) | Human | GLA | 1:3~1:4 | Negative | Online Inquiry |
GLA Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to elucidate the functional effects of the GLA gene, which encodes the enzyme galactosidase alpha. These knockout models effectively eliminate the expression of the GLA gene, allowing researchers to study the implications of its absence on cellular functions and biological pathways. By creating a targeted loss of function, scientists can gain deeper insights into gene role in metabolic processes and disease pathogenesis.
The key function of GLA knockout cell lines lies in their ability to model the absence of enzyme activity associated with the lysosomal storage disorder Fabry disease, caused by mutations in the GLA gene. Mechanistically, these cell lines facilitate the investigation of substrate accumulation, lysosomal function, and the cellular stress response, thus providing vital context for understanding related diseases and potential therapeutic targets.
Scientifically, GLA knockout cell lines are invaluable for both basic and applied research. They allow for the exploration of gene functions in disease models, drug discovery, and the development of potential therapeutic interventions. In clinical settings, these models can be pivotal for validating candidate drugs for Fabry disease or other conditions linked to GLA dysfunction, emphasizing their versatility in translational research.
Compared to conventional cell lines, GLA knockout cell lines offer enhanced specificity for studying the effects of GLA deficiency without confounding variables. The precise gene editing techniques employed in their development ensure a reliable and reproducible model for academic and industry-driven research.
For researchers and clinicians focused on genetics, metabolic disorders, or drug development, GLA Gene Knockout Cell Lines are essential tools that propel understanding and innovation. Our company specializes in developing high-quality biological products, backed by cutting-edge research and in-depth expertise in genetic engineering, positioning us as a leading provider of dependable cell models for the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.